We excluded participants with diabetes because among those receiving antidiabetic medications, both main parameters considered, HbA1c and insulin, would be altered depending on their treatment and also because, among untreated diabetic patients, the linearity of the relationship between HbA1c and other parameters disappears, which would have led to biased estimates had we included them. This evidence concerns the gene INS and diabetes mellitus.